-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, at the signing meeting of key projects of Hainan Free Trade Port in 2022 (the first batch), Haikou released 1,510 jobs for talents in the biomedical industry to the world
.
Specifically, Haikou's recruitment needs 106 doctoral degree or above, 130 master degree or above, 727 undergraduate degree or above; 209 research and development positions, 122 senior management positions, 262 inspection and testing positions, and engineering and technical positions.
21
.
From the perspective of annual salary, the salary for high-level talents in the field of biomedicine is between 500,000 and 3 million yuan
.
On March 30, Chengdu High-tech Zone also released the 2022 Chengdu High-tech Zone's first batch of Golden Panda high-level talent demand list, the first batch of postdoctoral recruiting lists, and the Chengdu High-tech Zone's high-end talent online service platform construction plan
.
It is reported that Chengdu High-tech Zone has released the first batch of Golden Panda high-level talent demand list for the world in 2022, and specially selected a group of high-level talent positions with an annual salary of 500,000 yuan to 3 million yuan
.
This batch of lists mainly focuses on the three leading industries of electronic information, biomedicine and new economy, bringing together more than 150 high-level positions in more than 30 key enterprises from Chengdu High-tech Zone
.
Among them, in the biopharmaceutical industry, in the high-level talent demand list released this time, there are many positions such as chief commercial officer and dean of biological research institutes provided by Chengdu Pioneer Division, Olin Bio and other companies, with an annual salary of more than 3 million yuan
.
Behind the recruitment orders for talents in the global biopharmaceutical industry in many places, the rapid rise of the biopharmaceutical industry in various parts of the country is in urgent need of high-level talents to help the high-quality development of the industry
.
Taking Haikou as an example, Haikou's biopharmaceutical industry has become an industry with rapid growth and high output efficiency.
At present, the scale of Haikou's biopharmaceutical industry is 37.
6 billion yuan, of which the total output value of the biopharmaceutical industry above designated size is 23.
5 billion yuan.
The operating income of circulation enterprises is 14.
1 billion yuan; 6 Haikou pharmaceutical enterprises have been certified by the EU and the US FDA, accounting for 8% of the country
.
According to the plan of Haikou's biopharmaceutical industry, by 2025, the biopharmaceutical industry in the area will achieve an operating income of 100 billion yuan and 200 billion yuan in 2030.
It will be built into a demonstration base for the integration and innovation of the biopharmaceutical system in a free trade port, and a biopharmaceutical free trade port.
The source of medical technology R&D and innovation, and the international biomedical production and manufacturing base in a free trade port
.
It is understood that the threshold for biomedical investment and research and development has always been relatively high, so the demand for mid-to-high-end talents has become very urgent
.
In recent years, the bio-pharmaceutical industry in Chengdu High-tech Zone has also developed by leaps and bounds.
Now it has formed a good industrial foundation and a large industrial scale.
There are more than 3,000 pharmaceutical companies in the area, and the scale of the bio-industry has maintained a growth rate of more than 20% for four consecutive years
.
In recent years, Chengdu has proposed to focus on the development of innovative drugs.
At present, many companies are accelerating the pace of research and development of innovative drugs
.
For example, Kelun Pharmaceutical has 63 new drugs under development, 14 of which have been approved for clinical use; Jingze Bio has more than 20 research projects, 4 of which are in clinical stage; Baiyu Pharmaceutical has more than 10 innovative drugs under development, and it is expected that there will be more than 10 new drugs under development this year.
2 entered the clinic
.
It is foreseeable that with the rapid development of the innovative drug industry, the demand of Chengdu enterprises for high-end pharmaceutical talents is also increasing day by day
.
At present, the domestic biopharmaceutical industry is still in its infancy, and the shortage of talents is serious
.
In order to better promote the development of the biopharmaceutical industry, policies have also been introduced in many places in recent years to strengthen the training of relevant talents
.
For example, Chongqing issued "Several Measures to Accelerate the Development of the Biomedical Industry in Chongqing", clearly strengthening the construction of talent teams; Yangzhou, Jiangsu recently issued a policy opinion on promoting the high-quality development of the biomedicine and new medical device industries, which proposed to encourage the introduction of talents, and to promote the introduction of talents.
Provide appropriate subsidies, rental subsidies,
etc.
"Testing and Calibration of Dry Body Temperature Calibrators" is about to be broadcast, welcome to sign up Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone
.
.
Specifically, Haikou's recruitment needs 106 doctoral degree or above, 130 master degree or above, 727 undergraduate degree or above; 209 research and development positions, 122 senior management positions, 262 inspection and testing positions, and engineering and technical positions.
21
.
From the perspective of annual salary, the salary for high-level talents in the field of biomedicine is between 500,000 and 3 million yuan
.
On March 30, Chengdu High-tech Zone also released the 2022 Chengdu High-tech Zone's first batch of Golden Panda high-level talent demand list, the first batch of postdoctoral recruiting lists, and the Chengdu High-tech Zone's high-end talent online service platform construction plan
.
It is reported that Chengdu High-tech Zone has released the first batch of Golden Panda high-level talent demand list for the world in 2022, and specially selected a group of high-level talent positions with an annual salary of 500,000 yuan to 3 million yuan
.
This batch of lists mainly focuses on the three leading industries of electronic information, biomedicine and new economy, bringing together more than 150 high-level positions in more than 30 key enterprises from Chengdu High-tech Zone
.
Among them, in the biopharmaceutical industry, in the high-level talent demand list released this time, there are many positions such as chief commercial officer and dean of biological research institutes provided by Chengdu Pioneer Division, Olin Bio and other companies, with an annual salary of more than 3 million yuan
.
Behind the recruitment orders for talents in the global biopharmaceutical industry in many places, the rapid rise of the biopharmaceutical industry in various parts of the country is in urgent need of high-level talents to help the high-quality development of the industry
.
Taking Haikou as an example, Haikou's biopharmaceutical industry has become an industry with rapid growth and high output efficiency.
At present, the scale of Haikou's biopharmaceutical industry is 37.
6 billion yuan, of which the total output value of the biopharmaceutical industry above designated size is 23.
5 billion yuan.
The operating income of circulation enterprises is 14.
1 billion yuan; 6 Haikou pharmaceutical enterprises have been certified by the EU and the US FDA, accounting for 8% of the country
.
According to the plan of Haikou's biopharmaceutical industry, by 2025, the biopharmaceutical industry in the area will achieve an operating income of 100 billion yuan and 200 billion yuan in 2030.
It will be built into a demonstration base for the integration and innovation of the biopharmaceutical system in a free trade port, and a biopharmaceutical free trade port.
The source of medical technology R&D and innovation, and the international biomedical production and manufacturing base in a free trade port
.
It is understood that the threshold for biomedical investment and research and development has always been relatively high, so the demand for mid-to-high-end talents has become very urgent
.
In recent years, the bio-pharmaceutical industry in Chengdu High-tech Zone has also developed by leaps and bounds.
Now it has formed a good industrial foundation and a large industrial scale.
There are more than 3,000 pharmaceutical companies in the area, and the scale of the bio-industry has maintained a growth rate of more than 20% for four consecutive years
.
In recent years, Chengdu has proposed to focus on the development of innovative drugs.
At present, many companies are accelerating the pace of research and development of innovative drugs
.
For example, Kelun Pharmaceutical has 63 new drugs under development, 14 of which have been approved for clinical use; Jingze Bio has more than 20 research projects, 4 of which are in clinical stage; Baiyu Pharmaceutical has more than 10 innovative drugs under development, and it is expected that there will be more than 10 new drugs under development this year.
2 entered the clinic
.
It is foreseeable that with the rapid development of the innovative drug industry, the demand of Chengdu enterprises for high-end pharmaceutical talents is also increasing day by day
.
At present, the domestic biopharmaceutical industry is still in its infancy, and the shortage of talents is serious
.
In order to better promote the development of the biopharmaceutical industry, policies have also been introduced in many places in recent years to strengthen the training of relevant talents
.
For example, Chongqing issued "Several Measures to Accelerate the Development of the Biomedical Industry in Chongqing", clearly strengthening the construction of talent teams; Yangzhou, Jiangsu recently issued a policy opinion on promoting the high-quality development of the biomedicine and new medical device industries, which proposed to encourage the introduction of talents, and to promote the introduction of talents.
Provide appropriate subsidies, rental subsidies,
etc.
"Testing and Calibration of Dry Body Temperature Calibrators" is about to be broadcast, welcome to sign up Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone
.
